AB Science S.A. (ABscience)

HQ Location

51 JFK Parkway, First Floor West
Short Hills, NJ 7078

Company Description

AB Science S.A., a pharmaceutical company, engages in the discovery, development, and commercialization of protein kinase inhibitors for use in human and veterinary medicine in the United States and Europe. It focuses on therapies for the treatment of cancer, inflammatory diseases, and nervous system diseases. The company's lead compound includes Masitinib, a tyrosine kinase inhibitor that targets mast cells and selected kinases, including c-Kit, PDGR, and Lyn. Masitinib is also in three ongoing Phase III trials for the treatment of various indications in humans. The company was founded in 2001 and is headquartered in Paris, France.